======= CCKBR ======= == Gene Information == * **Official Symbol**: CCKBR * **Official Name**: cholecystokinin B receptor * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=887|887]] * **UniProt**: [[https://www.uniprot.org/uniprot/P32239|P32239]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CCKBR&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CCKBR|Open PubMed]] * **OMIM**: [[https://omim.org/entry/118445|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a G-protein coupled receptor for gastrin and cholecystokinin (CCK), regulatory peptides of the brain and gastrointestinal tract. This protein is a type B gastrin receptor, which has a high affinity for both sulfated and nonsulfated CCK analogs and is found principally in the central nervous system and the gastrointestinal tract. Alternative splicing results in multiple transcript variants. A misspliced transcript variant including an intron has been observed in cells from colorectal and pancreatic tumors. [provided by RefSeq, Dec 2015]. * **UniProt Summary**: Receptor for gastrin and cholecystokinin. The CKK-B receptors occur throughout the central nervous system where they modulate anxiety, analgesia, arousal, and neuroleptic activity. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. |7tm 1| |gastrin receptor activity| |type B gastrin/cholecystokinin receptor binding| |cholecystokinin signaling pathway| |cholecystokinin receptor activity| |gastric acid secretion| |1-phosphatidylinositol-3-kinase regulator activity| |peptide hormone binding| |pH reduction| |regulation of phosphatidylinositol 3-kinase activity| |regulation of lipid kinase activity| |digestive system process| |acid secretion| |regulation of phospholipid metabolic process| |phospholipase C-activating G protein-coupled receptor signaling pathway| |regulation of pH| |digestion| |digestive tract development| |monovalent inorganic cation homeostasis| |digestive system development| |positive regulation of cytosolic calcium ion concentration| |regulation of cytosolic calcium ion concentration| |regulation of lipid metabolic process| |gland development| |cellular calcium ion homeostasis| |calcium ion homeostasis| |cellular divalent inorganic cation homeostasis| |divalent inorganic cation homeostasis| |cellular metal ion homeostasis| |metal ion homeostasis| |cellular cation homeostasis| |cellular ion homeostasis| |cation homeostasis| |inorganic ion homeostasis| |cellular chemical homeostasis| |ion homeostasis| |tube development| |regulation of kinase activity| |cellular homeostasis| |positive regulation of cell population proliferation| |regulation of transferase activity| |chemical homeostasis| |secretion| |G protein-coupled receptor signaling pathway| |regulation of phosphorylation| |regulation of cell population proliferation| |homeostatic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp492|iCRT14 30μM R08 exp492]]|-2.13| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|-2.01| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.418| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11934 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}